These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8796998)

  • 1. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
    DeClerck YA; Laug WE
    Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
    Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C; Dolo V; Guerra F; Violini S; Muzi P; Pavan A; Bologna M
    Clin Exp Metastasis; 1998 Aug; 16(6):513-28. PubMed ID: 9872599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases and protease inhibitors in tumor progression.
    DeClerck YA; Imren S; Montgomery AM; Mueller BM; Reisfeld RA; Laug WE
    Adv Exp Med Biol; 1997; 425():89-97. PubMed ID: 9433492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What structure and function of avian plasminogen activator and matrix metalloproteinase-2 reveal about their counterpart mammalian enzymes, their regulation and their role in tumor invasion.
    Alexander DS; Aimes RT; Quigley JP
    Enzyme Protein; 1996; 49(1-3):38-58. PubMed ID: 8796996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R; Rifkin DB
    Int J Cancer; 1990 Jul; 46(1):56-60. PubMed ID: 2142142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
    Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
    Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligonucleotide of tissue inhibitor of metalloproteinase-1 induces the plasminogen activator activity in periodontal ligament cells.
    Shibata Y; Takiguchi H; Abiko Y
    J Periodontol; 1999 Oct; 70(10):1158-65. PubMed ID: 10534069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy.
    Tyagi SC; Kumar SG; Haas SJ; Reddy HK; Voelker DJ; Hayden MR; Demmy TL; Schmaltz RA; Curtis JJ
    J Mol Cell Cardiol; 1996 Jul; 28(7):1415-28. PubMed ID: 8841929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
    Hewitt R; Danø K
    Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular extracellular matrix remodeling in cerebral aneurysms.
    Bruno G; Todor R; Lewis I; Chyatte D
    J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells.
    Cai G; Chen X; Fu B; Lu Y
    Mol Cell Biochem; 2005 Sep; 277(1-2):171-9. PubMed ID: 16132729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
    Pepper MS
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators and matrix metalloproteinases in angiogenesis.
    Mignatti P; Rifkin DB
    Enzyme Protein; 1996; 49(1-3):117-37. PubMed ID: 8797002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.
    Smit JW; van der Pluijm G; Romijn HA; Löwik CW; Morreau H; Goslings BM
    Thyroid; 1999 Sep; 9(9):913-9. PubMed ID: 10524570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.
    Moser TL; Young TN; Rodriguez GC; Pizzo SV; Bast RC; Stack MS
    Int J Cancer; 1994 Feb; 56(4):552-9. PubMed ID: 8112891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and metastasis.
    Kleiner DE; Stetler-Stevenson WG
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S42-51. PubMed ID: 10357558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator expression and matrix degradation.
    Rifkin DB
    Matrix Suppl; 1992; 1():20-2. PubMed ID: 1480022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.